Ashkan Shoamanesh
Overview
Explore the profile of Ashkan Shoamanesh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
160
Citations
3241
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tsivgoulis G, Katsanos A, Romoli M, Sarraj A, Krogias C, Karapanayiotides T, et al.
J Neurol Neurosurg Psychiatry
. 2025 Mar;
PMID: 40089306
Background: Current international guidelines suggest andexanet alfa (AA) for the management of factor Xa inhibitor-associated intracranial haemorrhage (ICH). However, those recommendations are based on low-quality evidence and there is uncertainty...
2.
3.
De Marchis G, Toebak A, Dittrich T, Vlachos D, Wang A, Smith E, et al.
Eur Stroke J
. 2025 Feb;
:23969873251323180.
PMID: 40008571
Introduction: Dual antiplatelet therapy (DAPT) is superior to single antiplatelet therapy (SAPT) for secondary prevention after minor, non-cardioembolic stroke. We aimed to assess whether DAPT efficacy is modified by large...
4.
Wang M, Baskaran G, Razeghi G, Ma R, Park L, Tannu M, et al.
Ann Intern Med
. 2025 Feb;
PMID: 39928949
Background: In several settings, therapeutic-dose non-vitamin K oral anticoagulants (NOACs) are superior to aspirin for the prevention of arterial and venous thromboembolism. Purpose: To estimate differences in bleeding risks between...
5.
Li Q, Lv X, Morotti A, Qureshi A, Dowlatshahi D, Falcone G, et al.
Neurology
. 2025 Feb;
104(5):e213412.
PMID: 39913881
Background And Objectives: Early intensive systolic blood pressure (SBP) reduction is a promising strategy for intracerebral hemorrhage (ICH), but the optimal magnitude of reduction in the first 2 hours remains...
6.
Balali P, Butcher K, Ng K, Joundi R, Joundi R, Kasner S, et al.
Can J Neurol Sci
. 2025 Jan;
:1-9.
PMID: 39882577
Background: Cerebral microbleeds are associated with an increased risk of hemorrhagic transformation (HT) following acute ischemic stroke. We investigated whether the effect of dabigatran (vs. aspirin) in patients with acute...
7.
Shoamanesh A, Field T, Coutts S, Sharma M, Gladstone D, Hart R, et al.
Lancet Neurol
. 2025 Jan;
24(2):140-151.
PMID: 39862882
Background: People with subclinical atrial fibrillation are at increased risk of stroke, albeit to a lesser extent than those with clinical atrial fibrillation, leading to an ongoing debate regarding the...
8.
Perera K, Sharma M, Eikelboom J, Ng K, Field T, Buck B, et al.
Stroke
. 2025 Jan;
56(2):380-389.
PMID: 39781748
Background: Stroke secondary to intracranial atherosclerotic disease (ICAD) is associated with high recurrence risk despite currently available secondary prevention strategies. In patients with systemic atherosclerosis, a significant reduction of stroke...
9.
Sposato L, Cameron A, Cameron A, Johansen M, Katan M, Murthy S, et al.
Int J Stroke
. 2024 Dec;
:17474930241312649.
PMID: 39719823
Background: Secondary stroke prevention in patients with atrial fibrillation (AF) is one of the fastest growing areas in the field of cerebrovascular diseases. This scientific statement from the World Stroke...
10.
Mai L, Joundi R, Katsanos A, Selim M, Shoamanesh A
Stroke
. 2024 Dec;
56(3):783-793.
PMID: 39676669
Recovery trajectories in intracerebral hemorrhage (ICH) are recognized as distinct from those observed in ischemic stroke. This narrative review aims to clarify the pathophysiology underlying ICH recovery patterns, highlighting the...